FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc, indicating an approved change related to this drug. The action typically refle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE (RIVASTIGMINE)